RxDoctor Payments Data

Sandra Bernal, PA

Family Medicine · San Antonio, TXNPI 1083288971

Payments from drug & device makers

$7,048in general payments, 2019–2025

Across 258 payments — averaging $27.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AstraZeneca$1K
  • Lilly USA, LLC$653
  • Intuitive Surgical$545
  • Amgen$451
  • AbbVie$363
  • plus $2K from 25 others

What the payments were for

  • Travel & lodging$5458%
  • Food & beverage$6,50392%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,048 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$26,045
Medicare patients
142
Services billed
893

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide35$52,390
Janumet XrSitagliptin Phos/Metformin Hcl11$5,160
Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp13$1,783
Albuterol Sulfate HfaAlbuterol Sulfate26$958
Atorvastatin Calcium83$886
Rosuvastatin Calcium33$583
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide23$535
Gabapentin43$492
Omeprazole30$490
Amlodipine Besylate72$487
Levothyroxine Sodium74$462
Tamsulosin Hcl30$446
Losartan Potassium54$426
Metoprolol Succinate39$423
Valsartan14$422

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,540$52,39035 claims
MerckJanumet Xr$26$5,16011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,760 family medicine providers in Texas.

Other family medicine in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →